Any attempt to improve the selectivity of anti-cancer agents must be based on genetic, phenotypic or pathophysiological differences distinguishing cancer cells and tissues from their normal counterparts. Molecular alterations underlying the process of malignant transformation and tumour progression not only comprise mutations, but also changes in transcription of normal genes controlling cellular functions whose dysregulation is critically associated with the expression of malignant phenotypes (Schutzbank et al., 1982; Birnbaum et al., 1987; Busch, 1990) . To improve the therapeutic index of anti-cancer agents strategies are thus being sought that would exploit such transformation-associated changes by rational drug design. For example, in malignant cells the expression of genes coding for membrane-based glucose transporters and glycolytic enzymes is frequently increased; this molecular alteration is pivotal to a metabolic hallmark of malignant cells, aerobic glycolysis (Birnbaum et al., 1987; Flier et al., 1987) . The capacity of cancer cells to metabolise glucose to lactic acid (Warburg et al., 1924; Aisenberg, 1961; Weber, 1977; Lyon et al., 1988) can be exploited to stimulate lactate production selectively in malignant tissues. This manipulation involves a temporary induction of hyperglycemia in tumourbearing hosts by i.v. infusion of glucose and results in an increased activity of H+ ions in malignant tissues (Jahde et al., 1982b; Wike-Hooley et al., 1984; Ward & Jain, 1988; Jahde et al., 1989; Hwang et al., 1991) . Since H+ ions are potent modulators of various types of chemical reactions, tumour-selective acidification can be made use of, in a second step, to increase the target cell-directed cytotoxicity of anticancer agents, e.g. alkylating drugs, acid-labile prodrugs, pHsensitive immunoconjugates, hyperthermia, or acid-labile liposomes Tietze et al., 1989; Lavie et al. 1991; Hiroaka & Hahn, 1989; Yatvin et al., 1980) .
The pathophysiological basis of this approach has so far been investigated almost exclusively in transplanted rodent tumours. With the use of invasive as well as noninvasive techniques for measuring pH, the H+ ion activity in a wide variety of animal tumours was shown to be increased following stimulation of aerobic glycolysis (Wike-Hooley et al., 1984; Ward & Jain, 1988; Jahde et al., 1982b; Jahde et al., 1989) . We are, however, only aware of few investigations analysing the H + ion activity in human tumours in situ following glucose-mediated stimulation of lactic acid production (Naeslund & Swenson, 1953; Ashby, 1966; Thistlethwaite, 1987; Lavie et al., 1991) . In these studies, only 25 individual tumours, including ten malignant melanomas, five female genital cancers and ten tumours of varying histology were analysed. To (Jahde et al.,1982b) . Under light ether anaesthesia, catheters were advanced into the right atrium via phlebotomy of the right jugular vein and connected to a flexible, freely rotating infusion line fixed to the neck of the animals. The infusion apparatus allowed for free movement of animals in specially designed glass cages (Jahde et al., 1982b) . Glucose or NaCl solutions were continuously infused with the aid of standard syringe pumps (Braun Melsungen, Melsungen, Germany) . Routinely, rats were connected to the infusion apparatus 1 day prior to the experiments. To maintain the patency of the catheters, NaCl solution (9 g 1-') was infused at a rate of 0.5 ml h-' until glucose infusion was initiated. The rate at which sterile glucose solution (0.4 g ml-') was infused was adjusted according to the desired PGC. In order to raise PGC to 30 + 3 mM, the infusion rate was set to 5.0 ml h-1 initially, and thereafter adjusted individually for each rat according to PGC determinations at intervals of 0.5-3 h. During steady state hyperglycemia (i.e. (Jahde et al., 1982a) . As previously discussed, pH measurements performed with electrodes of this size primarily reflect the H+ ion activity in extracellular fluid, with a small but not precisely known contribution by intracellular components (Jahde et al., 1982a) . Ag/AgCl electrodes (type 373, Ingold, Frankfurt a.M., Germany) were used as reference electrodes. These electrodes were connected to tissues (buffers) via a 2 M KCl interface and an agar bridge prepared by filling a glass capillary with an aqueous solution of NaCl (9 g 1`) and agar (10 g 1'; heated to 100°C Liver, kidney and skeletal muscle were used as control tissues. The technique used for pH measurements in kidney has been described (Jahde et al., 1982b artifacts caused by respiratory movements. Analyses of skeletal muscle were performed in muscles of the left thigh.
Arterial blood parameters
To monitor side-effects of high-dose glucose infusion on hemodynamics, arterial blood pressure was measured by a pressure-transducer (Peter von Berg, Kirchseeon/Eglharting, Germany) coupled to a monitor (Sirecust 961, Siemens, Erlangen, Germany) via a 24G cannula inserted into the abdominal aorta. Blood drawn from this cannula after 5 min of pressure registration was analysed for P02, pCO2, pH, K+, Na+ and hemoglobin with the use of a standard blood gas analyser (model 288 Blood Gas System, Ciba Coming Diagnostics, Fermwald, Germany). In addition, plasma protein concentration was determined by an Ektachem DT60 analyser (Kodak, Stuttgart, Germany).
Statistical evaluation
Descriptive statistical parameters (means, s.d.) were calculated and two-sample t-tests were applied to test for differences in two groups. The Bonferroni adjustment was used to adjust for multiple testing. P values less than 0.05 were judged to be of significance. Figures 1,3) . In Figure  4 , the glucose-mediated pH shift in individual xenograft lines is depicted as a function of H+ ion activity at normal PGC.
There was no statistically significant correlation between these parameters (R = 0.205).
Effect of different levels ofhyperglycemia on HI ion activity in human tumour xenografts To investigate the correlation between PGC and tumour pH in more detail, PGC of rnu/mu rats bearing MRI-H-221 xenografts was elevated to plateau values of 14 + 3, 19 + 3, or 30 ± 3 mM, respectively, and maintained at these levels for 4 h prior to pH measurements. The highest PGC was chosen according to studies on human volunteers and cancer patients in whom PGC levels of 30-35 mM have been generated safely by i.v. glucose infusion (Lippmann & Graichen, 1977; Forster, 1987; Krag et al., 1990 ). An increase in PGC to only about 2.5 times the normal value (14 ± 3 mM) was sufficient to cause an acidic pH shift in MRI-H-221 xenografts from 6.72 to 6.46 (P<0.004; Figure  7 ). At a PGC of 19 ± 3 mM, the mean intratumoural pH was 6.31 (P <0.05) and a further increase in blood glucose to 27-33 mM only resulted in a small further increment in tumour acidity (mean pH, 6.19; statistically not significant) ( Figure 5 ).
Dependence of intratumoural pH on duration of hyperglycemia To investigate the effect of various durations of hyperglycemia on the accumulation of acidic metabolites in human Figure 6 ). Conversely, the glucoseinduced downshift of pH was independent of the growth rate of individual xenograft lines as estimated by the time required to reach a mean tumour volume of 2 cm3 (R = -0.33). bMeasured at 5 h after the onset of infusion of mannitol solution (0.2 g ml ') at a rate of 100mg mannitol kg-' body weight min-'. cMeasured at 5 h after the initiation of glucose infusion (100 mg glucose kg-' body weight min-'; PGC 30 ± 3 mM). frequency distribution showed only a slight shift to the left at 4 h after PGC had been raised to 30± 3 mM (mean pH value, 7.08; range 6.73-7.36; P<0.05). Similar results were obtained for kidney ( Figure 7 ) and liver of tumour-bearing rnu/rnu rats (Table III) .
Systemic side effects of high-dose glucose infusion
To confirm the safety of the glucose infusion regimen and to check for artifacts possibly caused by systemic disturbances induced by osmotic diuresis, we measured blood pressure, arterial blood gases, hemoglobin and protein concentrations as well as serum electrolytes in untreated and hyperglycemic rats. As summarised in Table IV temporary hyperglycemia had only marginal effects on hemodynamic parameters as well as indicators of fluid and electrolyte homeostasis. The decrease in arterial pCO2 likely most is due to moderate hyperventilation of hyperglycemic rats (Volk et al., 1993) .
Discussion
Carbohydrate metabolism of malignant cells is characterised by two distinct features: a high rate of glucose uptake and the formation of lactic acid. In mammalian cells the uptake of glucose is accomplished by a family of integral membrane proteins referred to as glucose transporters (Mueckler et al., 1985; Gould & Bell, 1990) . These proteins display cell typespecific patterns of expression, hormone-responsiveness and transport properties (Gould & Bell, 1990) . In the process of malignant transformation, the number of glucose transporter molecules per cell is frequently upregulated (Birnbaum et al., 1987; Flier et al., 1987) . This overall change is paralleled by alterations in the normally cell type-specific relative expression frequencies of various transporter subtypes, in favour of those transporters which are not insulin-dependent (Yama- (Von Ardenne & Reitnauer, 1978; Jahde et al., 1982b; Wike-Hooley et al.,1984; Ward & Jain, 1988; Hwang et al., 1991; Jahde et al., 1989 (Jahde et al., 1982b) , these minor shifts of the pH histograms of normal tissues partly reflect organ-specific functional changes in tumour-bearing hosts during hyperglycemia, e.g. increased urine acidity in the case of kidney.
In view of the potential clinical use of pH-sensitive anticancer agents (Connors et al., 1964; Yatvin et al., 1980; Wike-Hooley et al., 1984; Ward & Jain, 1988; Lavie et al., 1991; Hiroaka & Hahn, 1989; Tannock & Rotin, 1989; Tietze et al., 1989; Jahde et al., 1989) but from mean values of 6.73 and 6.77, respectively, to 6.12 and 6.13 in pancreatic carcinoma STO and breast cancer SE. This hetereogeneity of the pH response, which in individual tumours could not be predicted from the H+ ion activity at normoglycemia, is due to cell type-specific differences in the rate of lactic acid production as well as tissue-specific differences in the transport of glucose and acidic metabolites. In Warburg's classical studies on human tumour tissues in vitro, the metabolic quotient indicating lactic acid production in the presence of oxygen (aerobic glycolysis), Qc°o2, varied by a factor of 5 between individual tumours (Warburg et al., 1924) , consistent with recent quantitations of lactate release from human tumour xenografts in vivo . Moreover, tumour blood flow, one of the most important determinants of glucose supply as well as lactic acid clearance, may vary by a factor of 10 among individual tumours of related histogenesis . As shown by Jahde et al. (1992) Jahde et al., 1989 (Kruger et al., 1991) . In healthy human volunteers as well as cancer patients, blood glucose levels ranging between 20 and 30 mM have been generated by high-dose i.v. glucose infusion (Forster, 1987; Krag et al., 1990) . Given adequate fluid volume replacement, this procedure was well tolerated. Since insulin secretion is not compromised in non-diabetic individuals, metabolic derangements characteristic of diabetic ketoacidosis do not occur following high-dose glucose infusion.
The activity of H+ ions in tumour tissues depends on an interplay of various determinants. Among these, the rate of lactic acid production as well as the interstitial and vacular transport of glucose and lactate are of particular importance. The predictive value of the results presented here for the pH response to glucose of human tumours in situ depends, therefore, on the validity of xenografts as models of cellular metabolism as well as histomorphological parameters governing substrate and metabolite transport in tissues. Both in vitro and in vivo, human tumour cells, with rare exceptions, respond to elevated extracellular concentrations of glucose by increased lactic acid production (Naeslund & Swenson, 1953; Eagle et al., 1958; Aisenberg, 1961; Ashby, 1966; Thistlethwaite, 1987; Lavie et al., 1991) . It is more difficult to predict whether acidic metabolites, once their production is stimulated, will indeed accumulate in human tumours in situ to a similar extent as observed in human tumour xenografts. The histomorphology of tumour xenografts does not always mirror the tissue architecture of primary tumours. In general, however, the vasculature of xenografted human tumours bears a high degree of resemblance in morphology as well as functional properties to the vascular network of primary tumours in situ (Vaupel et al., 1987; Konerding et al., 1989a; Konerding et al., 1989b) . It may thus be reasonably assumed that primary tumours will exhibit a similar pH response to glucose as their xenograft counterparts. This view is supported by pH measurements in human patients. As stated above, we are only aware of very few studies that have measured pH values in human primary tumours following stimulation of aerobic glycolysis. For example, in Ashby's series (1966) , the average pH of 9 malignant melanomas was 6.57-40 min after PGC had been raised to 23 mM.
pH measurements performed with semi-microelectrodes primarily reflect H+ ion activities in the extracellular space although, by destruction of cells, various intracellular compartments may contribute to pH readings ('aggregate' pH) (Jahde et al., 1982b) . The cytotoxic effects of pH-sensitive agents, on the other hand, are either dependent on extracellular or on intracellular H+ ion activity. For example, acidlabile prodrugs and pH-sensitive immunoconjugates may be activated in the interstitial space whereas the cytotoxicity of alkylating drugs and hyperthermia is sensitive to changes in intracellular pH. Although mammalian cells are able to maintain pH gradients across plasma membranes, marked alterations of extracellular pH are accompanied by parallel, although not fully equivalent shifts of intracellular pH (Tannock & Rotin, 1989; Jahde et al., 1989) . The pH measurements reported here, therefore, are likely to indicate not only an acidification of tumour interstitial fluid following stimulation of aerobic glycolysis, but also a shift of intracellular pH. This is supported by measurements of intracellular pH following stimulation of aerobic glycolysis with the use of nuclear magnetic resonance spectroscopy in vitro and in vivo (Desmoulin et al., 1986J. For example, Hwang et al. (1991 demonstrated a reduction of predominantly intracellular pH by 0.79 units in RIF-1 tumours following i.p. glucose administration. Thus, even though at normoglycemia malignant cells may be capable to maintain the intracellular pH within normal limits vis-a'-vis a slightly acidic microenvironment (Griffiths, 1991) , present evidence suggests that, by metabolic manipulations, not only the extracellular, but also intracellular pH can be reduced.
Tumour-selective modification of the cellular microenvironment deserves particular attention as a general approach to the development of more effective treatment modalities for solid tumours. As indicated by the present study, a selective increase in H+ ion activity in malignant tissues can be induced in a wide variety of malignant tumours of diverse histogenesis. Glucose, the biochemical response modifier used, in nontoxic (Forster, 1987; Krag et al., 1990) . Moreover, H+ ions are potent modulators of various types of chemical reactions. Several classes of anti-cancer agents with different mechanisms of action, as diverse as alkylating drugs, pH-sensitive immunoconjugates or hyperthermia, have been identified whose cytotoxicity is sensitive to changes in microenvironmental pH (Yatvin et al., 1980; Lavie et al., 1991; Hiroaka & Hahn, 1989; Jahde et al., 1989) . Acid-labile prodrugs of cytotoxic agents have been synthesised which are stable, and hence nontoxic at physiological pH Gluisenkamp et al., 1992) . At slightly acidic pH, these prodrugs decompose with the liberation of potent cytotoxic species. Thus, at pH 6.4 (i.e. the mean pH measured in human tumour xenografts following glucose-stimulated the present aerobic glycolysis) the potency of 'second generation' acid-labile prodrugs, as expressed in terms of drug concentrations required to achieve equivalent cell killing in vitro, increases by a factor of 10-20 as compared to pH 7.4 (Gliisenkamp et al., 1992) . We believe, therefore, that the results presented here encourage further exploration of this approach.
